At 4.5% CAGR, Europe Intermittent Catheters Market is Projected to be Worth US$ 1,121.79 Million by 2031, says Business Market Insights

According to Business Market Insights’ research, the Europe intermittent catheters market was valued at US$ 791.79 million in 2023 and is expected to reach US$ 1,121.79 million by 2031, registering a CAGR of 4.5% from 2023 to 2031. Growing preference for self-catheterization and increasing investments in urinary catheter developments and adoption of single-use catheters are among the critical factors attributed to drive the Europe intermittent catheters market growth.

Benign prostatic hyperplasia (BPH) and prostatitis are among the most common reasons for intermittent self-catheterization in men. Many women face difficulties in bladder control, which compels them to opt for intermittent self-catheterization, which assists them to lead a normal life. Companies in the catheter market are increasingly investing in efforts to introduce newer products. In 2022, Convatec introduced the GentleCath catheter line, which features FeelClean Technology, a groundbreaking innovation. The next-generation material used in GentleCath catheters with FeelClean Technology is naturally slippery when wet, negating the need for a coating. They reduce the risk of trauma or bleeding and the associated pain since they have low friction levels during insertion and do not become sticky when removed. Thus, the increasing preference for self-catheterization and investments in urinary catheter developments are likely to create significant growth opportunities in the market in the coming years.

On the contrary, complications associated with catheterization hampers the growth of Europe intermittent catheters market.

By product, the Europe intermittent catheters market is segmented into coated intermittent catheters and uncoated intermittent catheters. The coated intermittent catheters segment held 63.2% share of Europe intermittent catheters market share in 2023, amassing US$ 500.79 million. It is projected to garner US$ 722.50 million by 2031 to register 4.7% CAGR during 2023–2031.

In terms of indication, the Europe intermittent catheters market is segmented into urinary incontinence, general surgeries, spinal cord injuries, Parkinson’s Disease (PD), multiple sclerosis, and others. The urinary incontinence segment held 52.6% share of Europe intermittent catheters market share in 2023, amassing US$ 416.66 million. It is projected to garner US$ 596.61 million by 2031 to register 4.6% CAGR during 2023–2031.

Based on category, the Europe intermittent catheters market is female length catheters, male length catheters, and kid length catheters. The female length catheters segment held 71.3% share of Europe intermittent catheters market share in 2023, amassing US$ 564.58 million. It is projected to garner US$ 818.27 million by 2031 to register 4.7% CAGR during 2023–2031.

By system type, the Europe intermittent catheters market is bifurcated into closed intermittent catheters systems and open intermittent catheters systems. The closed intermittent catheters segment held 65.7% share of Europe intermittent catheters market share in 2023, amassing US$ 520.58 million. It is projected to garner US$ 754.75 million by 2031 to register 4.8% CAGR during 2023–2031.

In terms of end user, the Europe intermittent catheters market is segmented into hospitals, ambulatory surgical centers, home care settings, and others. The hospitals segment held 44.8% share of Europe intermittent catheters market share in 2023, amassing US$ 354.36 million. It is projected to garner US$ 483.07 million by 2031 to register 3.9% CAGR during 2023–2031.

Based on country, the Europe intermittent catheters market is categorized into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Our regional analysis states that Germany captured 26.5% share of Europe intermittent catheters market in 2023. It was assessed at US$ 209.84 million in 2023 and is likely to hit US$ 301.32 million by 2031, registering a CAGR of 4.6% during 2023–2031.

Key players operating in the Europe intermittent catheters market are Advin Health Care Pvt Ltd; B Braun SE; Boston Scientific Corp; Cardinal Health Inc; Coloplast Corp; Convatec Group Plc; Medical Technologies of Georgia, Inc.; Teleflex Inc; and Wellspect HealthCare;  and among others.

• In April, 2024: Wellspect HealthCare launched LoFric Origo Sleeve, a new line extension to its LoFric Origo catheter range. The new product is part of company’s LoFric Origo range. The product features a non-touch technique, including a thin cover that runs along the catheter tube. It forms a protective sleeve that allows for more hygienic handling.

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com